Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Developing small molecules to improve the lives of patients with genetically defined rare diseases80M100.00%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States80M100.00%